<DOC>
	<DOCNO>NCT02397590</DOCNO>
	<brief_summary>A phase I clinical trial compare pharmacokinetics safety fimasartan/Atorvastatin combination tablet coadministration fimasartan Atorvastatin healthy male volunteer .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetic Interaction Between Fimasartan Atorvastatin Healthy Male Volunteers</brief_title>
	<detailed_description>After subject sign informed consent voluntarily , go screening period within 21 day . Group 1 period 2 period 3 period A F A F+A B F F+A A C A F+A F D A F F+A E F+A F A F F+A A F At period take Fimasartan , subject Group blood sample 0 , 0.25 , 0.5 , 0.75 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 6 , 8 , 12 , 24 48 hour medication ( 15 time period ) . At period take Atorvastatin , subject Group blood sample 0 , 0.5 , 1 , 1.5 , 2 , 3 , 4 , 6 , 8 , 12 , 24 48 hour medication ( 12 time period ) . At period take Fimasartan Atorvastatin , subject Group blood sample 0 , 0.25 , 0.5 , 0.75 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 6 , 8 , 12 , 24 48 hour medication ( 15 time period ) .</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Healthy male subject , age 19 50 year screen . 2 . Body weight 19.0 28.0 ideal body weight ( IBW ) ( kg ) = { height ( cm ) 100 } * 0.9 1 . History illness may affect absorption , distribution , metabolism excretion ( hepatobiliary , renal , cardiovascular , endocrine ( e.g. , hypothyroidism ) , respiratory , gastrointestinal , hematooncology , central nervous system , psychiatric musculoskeletal system ) 2 . Hypotension ( systolic ≤ 100 mmHg diastolic ≤ 65 mmHg ) hypertension ( systolic ≥ 140 mmHg diastolic ≥ 90 mmHg ) , measure screen 3 . Evidence hereditary disease , include galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption . 4 . History gastrointestinal disease ( i.g. , Crohn 's disease , active peptic ulcer ) resection operation may affect absorption study drug ( exclude simple appendectomy herniorrhaphy ) ] 5 . Participation study within 2 month prior first administration study drug ( The finish time previous study day last administration study drug )</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Fimasartan</keyword>
</DOC>